A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine

Name: A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
License: Public Domain

Beijing Luzhu Biotechnology Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

vaccine-preventable diseases, herpes zoster

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 363655
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.